Charles Schwab Investment Management Inc. boosted its stake in Herbalife Ltd (NYSE:HLF - Free Report) by 13.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,057,219 shares of the company's stock after buying an additional 360,659 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 3.00% of Herbalife worth $26,384,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Boothbay Fund Management LLC purchased a new stake in Herbalife in the 4th quarter worth approximately $251,000. Northern Trust Corp lifted its position in Herbalife by 14.5% in the 4th quarter. Northern Trust Corp now owns 1,002,676 shares of the company's stock worth $6,708,000 after buying an additional 126,902 shares in the last quarter. Readystate Asset Management LP lifted its position in Herbalife by 748.1% in the 1st quarter. Readystate Asset Management LP now owns 114,495 shares of the company's stock worth $988,000 after buying an additional 100,995 shares in the last quarter. Q Global Advisors LLC purchased a new stake in Herbalife in the 4th quarter worth approximately $2,438,000. Finally, Arena Capital Advisors LLC CA lifted its position in Herbalife by 78.0% in the 1st quarter. Arena Capital Advisors LLC CA now owns 60,910 shares of the company's stock worth $526,000 after buying an additional 26,700 shares in the last quarter.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on HLF shares. Mizuho increased their target price on shares of Herbalife from $8.00 to $9.00 and gave the stock a "neutral" rating in a research report on Monday, July 28th. Citigroup cut their target price on shares of Herbalife from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Finally, Wall Street Zen downgraded shares of Herbalife from a "strong-buy" rating to a "buy" rating in a research report on Sunday, August 10th. Three research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $11.50.
Get Our Latest Research Report on Herbalife
Herbalife Trading Down 1.9%
NYSE:HLF opened at $9.4050 on Thursday. Herbalife Ltd has a 1 year low of $5.04 and a 1 year high of $10.83. The firm's fifty day simple moving average is $9.18 and its 200 day simple moving average is $7.96. The firm has a market capitalization of $969.75 million, a PE ratio of 2.97, a PEG ratio of 0.29 and a beta of 0.85.
Herbalife (NYSE:HLF - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.53 by $0.06. The business had revenue of $1.26 billion for the quarter, compared to analyst estimates of $1.27 billion. Herbalife had a net margin of 6.59% and a negative return on equity of 27.36%. Herbalife's revenue was down 1.7% compared to the same quarter last year. During the same period last year, the business posted $0.54 EPS. As a group, analysts anticipate that Herbalife Ltd will post 1.57 EPS for the current fiscal year.
Herbalife Company Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.